Phoenix Asia Holdings Ltd
corporate_fare Company Profile
Phoenix Asia Holdings Ltd (NASDAQ:PHOE) is a publicly traded company in the Real Estate & Construction sector. Wiseek has independently scored 4 items for PHOE at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-14, rated 8/10. Across its 4 most recent items scored 7 or higher, the top rating is 10/10, with 4 rated 8 or above. Recent SEC coverage for PHOE spans 20-F, 6-K.
Recent high-impact activity:
- Phoenix Asia Swings to Loss, Gross Margin Collapses to 4.6%
- Phoenix Asia Holdings to Acquire ACEA Pharma in Transformational $1 Billion Stock Deal, Issuing 100 Million New Shares
- Phoenix Asia to Issue 100M Shares for Pharma Acquisition, Signaling Massive Dilution and Strategic Pivot
- Phoenix Asia Holdings Reports Steep 68.6% Net Income Decline, Negative Operating Cash Flow, and $4.1M Dilutive Share Issuance
Financial Snapshot
Insider Transactions
PHOE files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.